Jeffrey Kuvin, chair of the proposed board, said “we are deeply disappointed” with the decision.

Q&A: Wayne Batchelor Reflects on the State of Medical Research Early in the Second Trump Term sciprian@crf.org Fri, 02/07/2025 - 15:01 Todd Neale TCTMD spoke with Batchelor about how executive orders on DEI and federal funding are impacting the…

The immediate impact for the medical sciences is unclear, but the symbolism is “very chilling,” one commentator says.

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices sciprian@crf.org Thu, 01/23/2025 - 16:07 Todd Neale Much has changed since the 2013 document came out, with new information on pacing devices, techniques, and more.

It’s not yet time to abandon seated BP measurements, but taking a look at supine readings may provide enhanced risk assessments.

The temporary pause will allow the company to investigate four neurovascular events seen in an external validation study.

All Eyes on PCI—Should Patients’ Family Members Watch Cases? hdellabella@crf.org Thu, 12/19/2024 - 11:53 Whether it’s in the cath lab or during a live case, having relatives present can lead to extra anxiety and impact care, operators say.

PLATO investigators dismiss the paper as nothing new, but some clinicians say that, after 15 years, it’s hard not to have doubts.

Many centers are not yet performing the procedure, but some financial relief is on the way in the new year.

Venous thromboembolism is a risk with several contemporary HRT formulations, consistent with earlier data.

Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.

There remains a need to identify patients who will derive benefits from adjunctive techniques on top of pulmonary vein isolation.

The lack of a significant decline in inconclusive readings across devices suggests improvements are needed in the algorithms.

Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions remain.

Though the results aren’t definitive, it’s not premature to suggest high-risk individuals take shelter on very hot days.